Clinical management of Staphylococcus aureus bacteremia: a review.
about
The Impact of Infectious Disease Specialist Consultation for Staphylococcus aureus Bloodstream Infections: A Systematic ReviewTowards Development of Small Molecule Lipid II Inhibitors as Novel AntibioticsCorrecting a Fundamental Flaw in the Paradigm for Antimicrobial Susceptibility TestingSynergistic antibacterial effects of herbal extracts and antibiotics on methicillin-resistant Staphylococcus aureus: A computational and experimental study.Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management.Impact of routine bedside infectious disease consultation on clinical management and outcome of Staphylococcus aureus bacteraemia in adultsIdentification of Low-Level Vancomycin Resistance in Staphylococcus aureus in the Era of InformaticsThe Impact of Reporting a Prior Penicillin Allergy on the Treatment of Methicillin-Sensitive Staphylococcus aureus Bacteremia.An educational forum to engage infectious diseases and microbiology residents in resource stewardship modelled after the Choosing Wisely campaignThe Staphylococcus aureus Chaperone PrsA Is a New Auxiliary Factor of Oxacillin Resistance Affecting Penicillin-Binding Protein 2APathogenesis of Staphylococcus aureus Bloodstream Infections.Clinical Reasoning of Infectious Diseases Physicians Behind the Use or Nonuse of Transesophageal Echocardiography in Staphylococcus aureus BacteremiaA novel chimeric lysin with robust antibacterial activity against planktonic and biofilm methicillin-resistant Staphylococcus aureus.Infective endocarditis following tumor necrosis factor-α antagonist therapy for management of psoriatic erythroderma: a case report.Human Infections with Staphylococcus aureus CC398.Gram-Positive Bacterial Infections: Research Priorities, Accomplishments, and Future Directions of the Antibacterial Resistance Leadership Group.Infectious diseases consultations can make the difference: a brief review and a plea for more infectious diseases specialists in Germany.Inhibition of bacterial and fungal pathogens by the orphaned drug auranofin.Ceftaroline as Salvage Monotherapy for Persistent MRSA Bacteremia.Paediatric Staphylococcus aureus bacteraemia: A single-centre retrospective cohort.The "Choosing Wisely" initiative in infectious diseases.Use of bacterial whole-genome sequencing to understand and improve the management of invasive Staphylococcus aureus infections.Clinical presentation, management and outcomes of Staph aureus bacteremia (SAB) in older adults.Risk factors for long-term mortality of Staphylococcus aureus bacteremia.Treatment of Staphylococcus aureus Infections.Association of Evidence-Based Care Processes With Mortality in Staphylococcus aureus Bacteremia at Veterans Health Administration Hospitals, 2003-2014.Expression of HLA-DRA and CD74 mRNA in whole blood during the course of complicated and uncomplicated Staphylococcus aureus bacteremia.The Risk of Cardiac Device-Related Infection in Bacteremic Patients Is Species Specific: Results of a 12-Year Prospective Cohort.Incidence, prevalence, and management of MRSA bacteremia across patient populations-a review of recent developments in MRSA management and treatment.Telavancin in the Treatment of Concurrent Staphylococcus aureus Bacteremia: A Retrospective Analysis of ATLAS and ATTAIN Studies.Trimethoprim-sulfamethoxazole versus vancomycin for severe infections caused by meticillin resistant Staphylococcus aureus: randomised controlled trial.Impact of prompt intervention in response to positive blood culture results during weekends by collaboration between infectious disease specialists and microbiology laboratory staff.Optimal duration of antimicrobial therapy for uncomplicated Gram-negative bloodstream infections.[Antibiotic stewardship and Staphylococcus aureus Bacteremia].Evaluation of Staphylococcus aureus Bacteremia: Academic and Community-Based Management Within the Same Health System.The Safety and Economic Impact of Cefazolin versus Nafcillin for the Treatment of Methicillin-Susceptible Staphylococcus aureus Bloodstream Infections.Assessment of linezolid prescriptions in three French hospitals.Two cases of serious rhabdomyolysis during linezolid treatment.Inhibition of the multidrug efflux pump LmrS from Staphylococcus aureus by cumin spice Cuminum cyminum.Complete adherence to evidence-based quality-of-care indicators for Staphylococcus aureus bacteremia resulted in better prognosis.
P2860
Q26751492-13550763-0C70-48C3-833C-B212A7A85D3AQ28552923-1E0BADE5-BD3B-4448-8325-12906C5FCE49Q33817871-82BFD5CD-0F3C-4CF7-AEC3-9EC3C2B79AD8Q34047858-DB76663A-8159-4BA7-82BA-117DAC73A361Q34478074-DDE5317B-7763-4133-A0FC-FD8829F98CACQ35875149-AE82E1DF-BB1B-4810-A269-52921544794AQ35920382-86C5C931-20B7-4A7D-A546-66538EA28D72Q36082891-FF134664-D712-48DA-8C17-12F59E52ADE7Q36277337-90FA4EB6-5CDB-4069-9E89-6281C915D8CFQ36644810-1C8597B9-4F53-4FBE-8379-7C652DADCBA4Q37347046-76D696B7-B64D-4581-9DCD-A525251A4EDEQ37403783-DB205B4E-9E19-4DCF-93B1-219CBFBF8834Q37571286-96C87D8A-10DA-494C-BEA9-98B2C4DD2D28Q37633600-E70FDF22-28B9-4882-88CA-C162208D811AQ38558452-7D530069-D471-4BD6-ABF5-6D222FE60B34Q38738512-21D2EEEE-F16E-4923-8E1C-627AD6C55C24Q38747527-74016310-732E-4CC8-BAEB-46795CE088D6Q38916441-80310F92-DE2E-41FB-8763-5212C4A45BC8Q38926404-53CC9569-8283-4069-B3B9-F859FDEB82ECQ38938393-2687EE31-3536-48E5-9311-9D20F28989F5Q39168976-4A9C01AE-3B67-4AE4-BC49-5523B4323BBDQ39392178-79FC7F38-0CC2-4B5F-B263-BC8BD350D64AQ39999696-D3E9D9B4-B764-49CC-A5E2-6E815B8BE9F7Q40000094-6622C8A2-C5E0-4058-9B55-0CC3A8E4D69EQ40049973-F82B06B3-31CF-4E5F-B93B-53DB8BF0FBC0Q40066467-F4845653-C2C6-4205-BF40-7A76B45C33FEQ40070900-97425946-C90F-4A6E-9898-20F51C4C3CDFQ40075208-01A2DF93-D97C-45AB-85DF-38509AE2D582Q40083539-8ADA6C5C-D700-4D49-835D-501C6A4F7B47Q40140334-AEB59223-A039-4A3B-8199-2EDF6DB44DE0Q40155946-12B865E4-E560-408C-AB81-6A4C881A7B0DQ40197716-7E0C23C7-6238-489C-A70B-C4A007F31997Q40223658-BEAAE8ED-F169-45F7-8A3A-1C28B9062125Q40264352-A582A258-4F49-4414-A972-77CCA3430420Q40293945-970235F6-DD16-43E6-9ADE-865E69615C72Q40305775-435A6A4D-CB6D-4161-8F02-767DDDF15C01Q40356411-C8038717-06F7-45D9-A651-E811297B8AD2Q40373420-B3413292-384D-4794-A613-070CC0BC1D8AQ40457919-6B46DFA9-B224-4DA3-A2C6-9E76C8AB0F24Q40515287-3A1C3BEE-3E1E-452E-9D8E-00D397700150
P2860
Clinical management of Staphylococcus aureus bacteremia: a review.
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Clinical management of Staphylococcus aureus bacteremia: a review.
@ast
Clinical management of Staphylococcus aureus bacteremia: a review.
@en
Clinical management of Staphylococcus aureus bacteremia: a review.
@nl
type
label
Clinical management of Staphylococcus aureus bacteremia: a review.
@ast
Clinical management of Staphylococcus aureus bacteremia: a review.
@en
Clinical management of Staphylococcus aureus bacteremia: a review.
@nl
prefLabel
Clinical management of Staphylococcus aureus bacteremia: a review.
@ast
Clinical management of Staphylococcus aureus bacteremia: a review.
@en
Clinical management of Staphylococcus aureus bacteremia: a review.
@nl
P2860
P356
P1476
Clinical management of Staphylococcus aureus bacteremia: a review.
@en
P2093
Christopher Arnold
Thomas L Holland
P2860
P304
P356
10.1001/JAMA.2014.9743
P407
P577
2014-10-01T00:00:00Z